Part 2/Chapter 6/13-min read

Thoracic and Complex Aortic Disease

Thoracic aortic aneurysms, dissection, and complex aortic pathology including TEVAR

Edited by Tal M. Hörer MD, PhD · David T. McGreevy MD, PhD·Reviewed ·9 sections · 26 references

Aortic Dissection Classification

Aortic dissection occurs when an intimal tear allows blood to enter the medial layer, creating a false lumen that propagates along the aorta. It represents one of the most lethal cardiovascular emergencies, with untreated Type A dissection mortality approaching 1% per hour early after symptom onset.

Stanford Classification

The Stanford system divides dissections based on involvement of the ascending aorta.

  • Type A: Any dissection involving the ascending aorta, regardless of the site of primary intimal tear. Requires emergent surgical intervention due to high risk of rupture, tamponade, aortic regurgitation, and coronary malperfusion.
  • Type B: Dissection confined to the descending aorta (distal to the left subclavian artery). Management depends on presence of complications.

Modern classification frameworks from the American Heart Association (AHA), American College of Cardiology (ACC), and the European Society for Vascular Surgery (ESVS) also recognize "Non-A Non-B" dissections, which involve the aortic arch but spare the ascending aorta .

DeBakey Classification

The DeBakey system provides anatomic detail based on origin and extent.

  • Type I: Originates in ascending aorta and extends to at least the aortic arch, often to the descending aorta or beyond.
  • Type II: Originates in and is confined to the ascending aorta.
  • Type IIIa: Originates in descending thoracic aorta and extends distally but remains above the diaphragm.
  • Type IIIb: Originates in descending thoracic aorta and extends below the diaphragm.
Table 6.2DiagnosticAortic Dissection Classification Systems
Type A
**DeBakey**
Type I
**Anatomic Extent**
Ascending → arch → descending
**Primary Management**
Emergent open surgery
Type A
**DeBakey**
Type II
**Anatomic Extent**
Ascending only
**Primary Management**
Emergent open surgery
Type B
**DeBakey**
Type IIIa
**Anatomic Extent**
Descending thoracic only
**Primary Management**
Medical ± thoracic endovascular aortic repair (TEVAR)
Type B
**DeBakey**
Type IIIb
**Anatomic Extent**
Descending → abdominal
**Primary Management**
Medical ± TEVAR

Temporal Classification

Timing from symptom onset influences treatment strategy and aortic wall characteristics. Contemporary guidelines define four distinct phases: hyperacute (<24 hours), acute (1–14 days), subacute (15–90 days), and chronic (>90 days) . This classification is critical because the aortic wall's friability and the potential for favorable remodeling after TEVAR vary substantially across these timeframes .

Type B Aortic Dissection Management

Type B aortic dissection (TBAD) presents distinct management challenges based on clinical presentation, anatomic extent, and timing, with contemporary practice guided by society guidelines and long-term outcomes studies.

Complicated versus Uncomplicated TBAD

Complicated TBAD is defined by one or more of the following high-risk features requiring intervention:

  • Malperfusion syndrome: Visceral, renal, or limb ischemia from true lumen compression or branch vessel involvement
  • Rupture or impending rupture: Hemothorax, periaortic hematoma, rapidly expanding false lumen
  • Refractory hypertension: Despite optimal medical therapy (OMT) with multiple agents
  • Refractory pain: Persistent severe back/chest pain suggesting ongoing dissection
  • Rapid aortic expansion: Greater than 5 mm growth in less than 6 months
  • Maximum aortic diameter exceeding 40 mm during the acute phase (a strong predictor of late complications)

Uncomplicated TBAD lacks these features and may be managed with medical therapy alone in the acute setting, though long-term surveillance is mandatory. Recent guidelines from the American Heart Association (AHA), American College of Cardiology (ACC), and the European Society for Vascular Surgery (ESVS) emphasize identifying "high-risk" uncomplicated patients who may benefit from early intervention.

Medical Management

All patients with TBAD require aggressive blood pressure and heart rate control to reduce aortic wall stress:

  • Target systolic blood pressure: Less than 120 mmHg
  • Target heart rate: Less than 60 beats per minute to reduce dP/dt

First-line agents include intravenous beta-blockers (esmolol for titratability, labetalol for combined alpha/beta blockade). Non-dihydropyridine calcium channel blockers (diltiazem, verapamil) may be added for rate control. Vasodilators (nicardipine, nitroprusside) address residual hypertension only after adequate heart rate control to prevent reflex tachycardia.

Pain control with opioids is essential—pain drives sympathetic activation and hypertension, creating a destructive feedback loop. Long-term medical therapy includes oral beta-blockers, statins for cardiovascular risk reduction, and aggressive management of hypertension. Smoking cessation is critical given the elevated risk of late aneurysmal degeneration.

Thoracic endovascular aortic repair (TEVAR) has become the preferred intervention for complicated TBAD when anatomy permits. TEVAR seals the primary entry tear, redirecting flow into the true lumen and promoting false lumen thrombosis with favorable aortic remodeling.

In stable subacute/chronic TBAD, the INSTEAD randomized trial showed no early survival advantage at 2 years with TEVAR plus optimal medical therapy compared with optimal medical therapy alone, while longer follow-up in INSTEAD-XL demonstrated improved aorta-specific outcomes emerging over time, consistent with a remodeling-mediated benefit.

In acute uncomplicated TBAD, randomized data suggest TEVAR can improve aortic remodeling compared with medical therapy alone. Current consensus suggests that for high-risk uncomplicated TBAD, TEVAR should ideally be performed in the subacute phase (2 weeks to 3 months) to maximize remodeling potential while minimizing the risk of retrograde Type A dissection.

Indications for TEVAR in TBAD

According to STS/AATS 2022, AHA/ACC 2022, and ESVS 2026 guidance:

  • Definite indication: Complicated TBAD (rupture, malperfusion) with suitable anatomy
  • Strong consideration (High-risk features): Uncomplicated TBAD with a primary entry tear >10 mm, entry tear on the outer curvature of the arch, false lumen diameter greater than 22 mm, or total aortic diameter greater than 40 mm
  • May consider: Prophylactic TEVAR in uncomplicated TBAD to reduce late aortic events, particularly in the subacute phase for patients with suitable anatomy and low procedural risk

Technical Considerations

Adequate proximal landing zone (typically ≥2 cm of non-dissected aorta) is essential for secure seal. When the entry tear is in the arch, coverage of the left subclavian artery (LSA) may be required. Elective LSA revascularization is recommended (Class I) when coverage compromises antegrade flow to reduce posterior circulation stroke, arm ischemia, and spinal cord ischemia risk.

Spinal cord protection measures apply when: * Coverage exceeds 20 cm of thoracic aorta * Landing zone is within 2 cm of the celiac artery * Prior abdominal aortic repair exists

The multimodal spinal cord protection bundle includes: cerebrospinal fluid (CSF) drainage (maintain pressure less than 10 mmHg), mean arterial pressure (MAP) greater than 80–90 mmHg, hemoglobin optimization (greater than 10 g/dL), and staged procedures when feasible.

Persistent false lumen perfusion and partial thrombosis after TBAD are associated with worse late outcomes and help identify patients who require closer follow-up and may benefit from pre-emptive intervention.

Type A Aortic Dissection

Type A aortic dissection (TAAD) constitutes a surgical emergency. Without intervention, early mortality is high, driven by aortic rupture, cardiac tamponade, acute aortic regurgitation, coronary malperfusion, or stroke. Current guidelines emphasize that management by a multidisciplinary aortic team in high-volume centers is associated with improved survival .

Clinical Presentation

The classic presentation is sudden, severe "tearing" or "ripping" chest pain radiating to the back. However, presentations vary widely. Clinicians should maintain a high index of suspicion in patients with known genetic predispositions (e.g., Marfan syndrome) or a strong family history of aortic disease :

  • Anterior chest pain: Suggests ascending aortic involvement
  • Interscapular pain: Suggests arch or descending extension
  • Syncope: May indicate tamponade, stroke, or severe hypotension
  • Neurologic deficits: Stroke (arch vessel involvement), paraplegia (spinal cord ischemia)
  • Limb ischemia: Pulse deficits from iliac extension or obstruction
  • Abdominal pain: Visceral malperfusion

Physical examination may reveal blood pressure (BP) differential between arms (greater than 20 mmHg), new aortic regurgitation murmur, or signs of tamponade (hypotension, elevated jugular venous pressure (JVP), muffled heart sounds).

Diagnosis

Computed tomography angiography (CTA) is the diagnostic modality of choice—rapid, widely available, and highly sensitive and specific . Findings include intimal flap, true and false lumens, and extent of dissection. Transesophageal echocardiography (TEE) is an important adjunct, particularly for assessing aortic valve involvement, pericardial effusion, and coronary ostia.

Surgical Management

Emergent open surgical repair is the standard of care for TAAD. Initial medical management focuses on aggressive heart rate (HR) and blood pressure (BP) control, typically targeting a systolic blood pressure (SBP) < 120 mmHg and a heart rate < 60 beats per minute (bpm) to reduce aortic wall stress .

  • Ascending aorta replacement: With or without aortic root replacement. In suitable patients, valve-sparing root replacement (VSRR) is preferred over a composite graft (Bentall procedure) to avoid long-term anticoagulation .
  • Hemiarch repair: Replacement of the lesser curvature of the arch under hypothermic circulatory arrest.
  • Total arch replacement: Indicated when the arch is aneurysmal, contains a primary entry tear, or is extensively dissected. This may involve the "frozen elephant trunk" (FET) technique to facilitate future distal repair .

Adjunctive measures include antegrade cerebral perfusion during circulatory arrest to reduce neurologic injury. Contemporary registry data and guideline syntheses support operative repair as the default strategy in eligible patients, with outcomes influenced by malperfusion, age, and center experience.

Hybrid and Endovascular Approaches

Selected TAAD cases may be candidates for hybrid approaches combining open ascending repair with endovascular arch/descending treatment. Purely endovascular Type A repair remains investigational and is limited to highly selected patients who are prohibitive surgical risks .

Complex AAA and TAAA

Planning essentials for complex endovascular repair include careful assessment of sheath access requirements (typically 16–22 Fr), selection of appropriate bridging stents for target vessels (covered or bare-metal based on vessel length and tortuosity), renal protection strategies (hydration, contrast-sparing protocols, and avoidance of nephrotoxic agents), and consideration of staged procedures in extensive 6Thoracic Aortic repairs to reduce spinal cord ischemia risk. Outcomes from experienced centers demonstrate target vessel patency rates typically exceeding 90% at 1–3 years, though endoleak rates remain significant (Type Ia 3–8%, Type II 10–20%) and reintervention rates range from 15–25% at mid-term follow-up. For basic 4Aneurysms repair principles, see 4Chapter 4.

Thoracic Aortic Aneurysm

  • Descending 6Thoracic Aortic: thoracic endovascular aortic repair (TEVAR) is preferred in suitable anatomy, especially in older/high-risk patients; open repair remains for unsuitable anatomy or infection.
  • Ascending/arch: Managed with open or hybrid strategies; branched/fenestrated arch endografts are emerging but limited to select anatomy/centers.
  • Thresholds: Consider repair at ≥6.0 cm for descending 6Thoracic Aortic (≥5.5 cm with risk factors) and ≥5.5 cm for ascending/arch (lower thresholds with bicuspid valve and risk factors or genetic aortopathy); index to body size in small patients. Connective tissue disorders warrant earlier repair and avoidance of TEVAR when durable proximal/distal fixation is not achievable.
  • LSA management: In TEVAR, intentional LSA coverage may be required; plan revascularization electively when possible to mitigate stroke/SCI/arm ischemia.

Landmark endograft studies and contemporary society guidelines support TEVAR as the preferred approach for many descending thoracic aneurysms in appropriate anatomy, while emphasizing individualized threshold selection and connective tissue disorder considerations.

Ruptured Thoracic Aortic Aneurysm

  • Ruptured 6Thoracic Aortic: very high early mortality; thoracic endovascular aortic repair (TEVAR) is preferred for descending rTAA when anatomically feasible due to lower perioperative morbidity vs open repair; open repair for unsuitable anatomy, infection, or genetic aortopathy.
  • Technical: Rapid proximal seal; intentional left subclavian artery (LSA) coverage acceptable in emergencies with planned revascularization when indicated; apply spinal cord protection principles as feasible. For vascular trauma management principles, see 16EVTM.

Observational outcomes literature and guideline statements generally favor TEVAR over open repair for ruptured descending thoracic aneurysm when anatomy permits, acknowledging selection bias and the need for rapid hemorrhage control.

Thoracic aortic aneurysm thresholds (ascending, arch, descending) and genetic disease considerations

Surgical thresholds for the ascending aorta and arch are generally ≥5.5 cm, with lower thresholds in patients with bicuspid valve disease and risk factors or syndromic aortopathy. For the descending aorta, the threshold is ≥6.0 cm, though ≥5.5 cm may be considered with risk factors or rapid growth. The aortic size index should be used in small patients. Earlier thresholds apply in Marfan, Loeys-Dietz, and Ehlers-Danlos syndromes per guidelines, and natural history data support increasing adverse event risk with larger diameters.

Table 6.1TreatmentThoracic Aortic Aneurysm Repair Thresholds
Ascending aorta
**Standard Threshold**
≥5.5 cm
**With Risk Factors**
≥5.0 cm
**Genetic Aortopathy**
≥4.5–5.0 cm (syndrome-specific)
Aortic arch
**Standard Threshold**
≥5.5 cm
**With Risk Factors**
≥5.0 cm
**Genetic Aortopathy**
≥4.5–5.0 cm
Descending aorta
**Standard Threshold**
≥6.0 cm
**With Risk Factors**
≥5.5 cm
**Genetic Aortopathy**
≥5.0–5.5 cm

TAAA classification and spinal cord protection bundle

The Crawford classification helps predict spinal cord ischemia (SCI) risk. Major risk factors include extent of coverage, prior 4Aneurysms repair, hypotension, and coverage of the LSA or IMA. A prevention bundle is recommended, including preoperative risk assessment, selective CSF drainage, maintenance of MAP >80–90 mmHg, hemoglobin optimization, LSA revascularization when feasible, and staged procedures. These principles apply to open, thoracic endovascular aortic repair (TEVAR), and BEVAR approaches.

Crawford Classification of TAAA

ClassificationType and Extent and SCI Risk
I
**Extent**
Distal to L-subclavian to above renals
**SCI Risk**
10–15%
II
**Extent**
Distal to L-subclavian to aortic bifurcation
**SCI Risk**
15–30%
III
**Extent**
Distal thoracic aorta to aortic bifurcation
**SCI Risk**
5–10%
IV
**Extent**
Below diaphragm to aortic bifurcation
**SCI Risk**
2–5%
V
**Extent**
Distal to L-subclavian to celiac origin
**SCI Risk**
5–10%

Open and endovascular series demonstrate that outcomes are strongly influenced by extent (particularly type II), perioperative hemodynamics, and protocolized spinal cord protection.

Surveillance After Aortic Dissection

All patients surviving aortic dissection require lifelong imaging surveillance regardless of initial treatment strategy. The dissected aorta remains at risk for late complications including aneurysmal degeneration of the false lumen, new dissection, and disease progression.

Surveillance Protocol

Recommended imaging intervals after dissection or thoracic endovascular aortic repair (TEVAR):

  • 1 month: Baseline post-treatment computed tomography angiography (CTA)
  • 3 months: Early follow-up to assess remodeling
  • 6 months: Intermediate assessment
  • 12 months: Annual milestone
  • Annually thereafter: Lifelong surveillance
  • More frequent imaging if concerning features develop (sac growth, new symptoms, endoleak)

These intervals reflect common guideline-based surveillance patterns intended to detect early complications and late aneurysmal degeneration.

Favorable Prognostic Indicators

After TEVAR for TBAD, false lumen thrombosis indicates favorable aortic remodeling and is associated with reduced late adverse events. Complete thrombosis of the thoracic false lumen is the goal; persistent perfusion of the false lumen via distal re-entry tears may limit remodeling, and partial thrombosis has been associated with worse outcomes in dissection cohorts.

Medical Optimization During Surveillance

Lifelong medical therapy is essential:

  • Blood pressure control (target less than 130/80 mmHg)
  • Beta-blockade to reduce wall stress
  • Statin therapy for cardiovascular risk reduction
  • Smoking cessation (strongly emphasized)

Patients with connective tissue disorders require genetic counseling and family screening. First-degree relatives should be offered imaging surveillance given familial clustering of thoracic aortic disease.

References

  1. 1.
    AHA. ACC/AHA Aortic Disease Guidelines: What Was Simple Is Now Complex-Moving to Multidisciplinary Teams, Specialized Centers. J Am Coll Cardiol. 2022. PMID: 36480976. DOI: 10.1016/j.jacc.2022.11.007.
    PubMed-indexed articleClinical practice guideline2026
    PubMedDOI
  2. 2.
    Daily PO, Trueblood HW, Stinson EB, Wuerflein RD, Shumway NE. Management of acute aortic dissections. Ann Thorac Surg. 1970;10(3):237-247.
    PubMed-indexed article1970
    PubMedOpen PDF
  3. 3.
    DeBakey ME, Henly WS, Cooley DA, Morris GC Jr, Crawford ES, Beall AC Jr. Surgical management of dissecting aneurysms of the aorta. J Thorac Cardiovasc Surg. 1965;49:130-149.
    PubMed-indexed article1965

    Experience with surgical management of 179 patients with dissecting aneurysms of the aorta during the past decade has allowed development of certain conceptual changes and new methods of operative treatment based on a better understanding of the anatomic and pathologic patterns of the disease.

    PubMedOpen PDF
  4. 4.
    Erbel R, Aboyans V, Boileau C, et al. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases. Eur Heart J. 2014;35(41):2873-2926.
    PubMed-indexed articleClinical practice guideline2014
    PubMedDOI
  5. 5.
    European Society for Vascular Surgery (ESVS). 2026 Clinical Practice Guidelines on the Management of Descending Thoracic and Thoraco-Abdominal Aortic Diseases. Eur J Vasc Endovasc Surg. 2025. PMID: 41448425. DOI: 10.1016/j.ejvs.2025.12.050.
    PubMed-indexed articleClinical practice guideline2025

    These 2025 ESVS clinical practice guidelines provide comprehensive and up to date advice to physicians and patients on the management of diseases of the mesenteric and renal arteries and veins.

    PubMedDOISource
  6. 6.
    Hagan PG, Nienaber CA, Isselbacher EM, et al. The International Registry of Acute Aortic Dissection (IRAD): New Insights Into an Old Disease. JAMA. 2000;283(7):897–903.
    PubMed-indexed article2000

    The data support the need for continued improvement in prevention, diagnosis, and management of acute aortic dissection and suggest a high clinical index of suspicion is necessary.

    PubMedOpen PDF
  7. 7.
    Isselbacher EM, Preventza O, Hamilton Black J 3rd, et al. 2022 ACC/AHA guideline for the diagnosis and management of aortic disease. J Am Coll Cardiol. 2022;80(24):e223-e393.
    PubMed-indexed articleClinical practice guideline2022

    Recommendations from previously published AHA/ACC guidelines on thoracic aortic disease, peripheral artery disease, and bicuspid aortIC valve disease have been updated with new evidence to guide clinicians and there is added emphasis on the role of shared decision making in the management of patients with aorti disease both before and during pregnancy.

    PubMedDOIOpen PDF
  8. 8.
    Writing Committee Members. 2022 ACC/AHA guideline for the diagnosis and management of aortic disease: A report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. J Thorac Cardiovasc Surg. 2023. PMID: 37389507.
    PubMed-indexed articleClinical practice guideline2023
    PubMedDOI
  9. 9.
    Brunkwall J, Kasprzak P, Verhoeven E, et al. Endovascular repair of acute uncomplicated aortic type B dissection promotes aortic remodelling: 1 year results of the ADSORB trial. Eur J Vasc Endovasc Surg. 2014;48(3):285-291.
    PubMed-indexed articleRandomized controlled trial2014

    Uncomplicated AD can be safely treated with the Gore TAG device and Remodelling with thrombosis of the false lumen and reduction of its diameter is induced by the stent graft, but long term results are needed.

    PubMedDOIOpen PDF
  10. 10.
    Hiratzka LF, Bakris GL, Beckman JA, et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease. Circulation. 2010;121(13):e266-e369.
    PubMed-indexed articleClinical practice guideline2010
    PubMedDOIOpen PDF
  11. 11.
    MacGillivray TE, Gleason TG, Patel HJ, et al. The Society of Thoracic Surgeons/American Association for Thoracic Surgery Clinical Practice Guidelines on the Management of Type B Aortic Dissection. Ann Thorac Surg. 2022;113(4):1073–1092.
    PubMed-indexed article2022

    The lack of high-quality data from randomized clinical trials limits the ability to make strong evidenced-based recommendations in several high-priority areas, including the optimal timing for intervention on TBAD patients with high-risk features or the routine use of TEVAR in uncomplicated TBAD to prevent long-term aortic-related complications and death.

    PubMedOpen PDF
  12. 12.
    Matsumura JS, Lee WA, Mitchell RS, et al. The Society for Vascular Surgery Practice Guidelines: management of the left subclavian artery with thoracic endovascular aortic repair. J Vasc Surg. 2009;50(5):1155-1158.
    PubMed-indexed articleClinical practice guideline2009

    The Society for Vascular Surgery pursued development of clinical practice guidelines for the management of the left subclavian artery with thoracic endovascular aortic repair by selecting a panel of experts and conducting a systematic review and meta-analysis of the literature.

    PubMedDOIOpen PDF
  13. 13.
    Nienaber CA, Rousseau H, Eggebrecht H, et al. Randomized comparison of strategies for type B aortic dissection: the INvestigation of STEnt Grafts in Aortic Dissection (INSTEAD) trial. Circulation. 2009;120(25):2519-2528.
    PubMed-indexed articleRandomized controlled trial2009

    In the first randomized study on elective stent-graft placement in survivors of uncomplicated type B aortic dissection, TEVAR failed to improve 2-year survival and adverse event rates despite favorable aorti remodeling.

    PubMedDOI
  14. 14.
    Nienaber CA, Kische S, Rousseau H, et al. Endovascular repair of type B aortic dissection: long-term results of the randomized investigation of stent grafts in aortic dissection (INSTEAD-XL). Circulation. 2013;127(24):2498-505.
    PubMed-indexed article2013

    In patients with pulmonary embolism at intermediate risk, a standardized USAT regimen was superior to anticoagulation with heparin alone in reversing RV dilatation at 24 hours, without an increase in bleeding complications.

    PubMedOpen PDF
  15. 15.
    Tsai TT, Evangelista A, Nienaber CA, et al. Partial thrombosis of the false lumen in patients with acute type B aortic dissection. N Engl J Med. 2007;357(4):349-359.
    PubMed-indexed articleRegistry / cohort2007

    Mortality is high after discharge from the hospital among patients with type B acute aortic dissection and partial thrombosis of the false lumen, as compared with complete patency, is a significant independent predictor of postdischarge mortality.

    PubMedDOIOpen PDF
  16. 16.
    Trimarchi S, Nienaber CA, Rampoldi V, et al. Role and results of surgery in acute type B aortic dissection: insights from the International Registry of Acute Aortic Dissection (IRAD). Circulation. 2006;114(1 Suppl):I357-I364.
    PubMed-indexed articleRegistry / cohort2005

    Insight into current-day clinical profiles and surgical outcomes of ABAD is provided by identifying primary factors that influenced surgical outcome and estimating average surgical mortality for ABAD in the current era.

    PubMedDOI
  17. 17.
    Oderich GS, et al. BEVAR outcomes. *J Vasc Surg*. 2017. PubMed
    PubMed-indexed article2017

    AWT predicts solid organ infarction, renal function deterioration, and longer time to resume enteral diet after F‐BEVAR of pararenal and type IV TAAAs and presents a new classification system for assessment of AWT burden.

    PubMedDOIOpen PDF
  18. 18.
    Oikonomou K, et al. ChEVAR outcomes (PERICLES). *J Vasc Surg*. 2019. PubMed
    PubMed-indexed article2019

    A model where integrin &agr;v and cellular interactions with the extracellular matrix are required to maintain VANGL2 protein levels and thus function at the plasma membrane is supported.

    PubMedOpen PDF
  19. 19.
    Dake MD, Miller DC, Semba CP, Mitchell RS, Walker PJ, Liddell RP. Transluminal placement of endovascular stent-grafts for the treatment of descending thoracic aortic aneurysms. N Engl J Med. 1994;331(26):1729-1734.
    PubMed-indexed article1994

    These preliminary results demonstrate that endovascular stent-graft repair is safe in highly selected patients with descending thoracic aortic aneurysms and will, however, require careful long-term evaluation.

    PubMedDOIOpen PDF
  20. 20.
    Szeto WY, McGarvey M, Pochettino A, et al. Results of a new surgical paradigm: endovascular repair for acute complicated type B aortic dissection. Ann Thorac Surg. 2008;86(1):87-93.
    PubMed-indexed article2008

    Endovascular repair of acute complicated type B aortic dissection is associated with low morbidity and mortality and has emerged as the surgical therapy of choice.

    PubMedDOIOpen PDF
  21. 21.
    Jonker FH, Trimarchi S, Verhagen HJ, Moll FL, Sumpio BE, Muhs BE. Meta-analysis of open versus endovascular repair for ruptured descending thoracic aortic aneurysm. J Vasc Surg. 2010;51(4):1026-1032.
    PubMed-indexed articleMeta-analysis / systematic review2010

    Endovascular repair of rDTAA is associated with a significantly lower 30-day mortality rate compared with open surgical repair, and TEVAR wasassociated with a considerable number of aneurysm-related deaths during follow-up.

    PubMedDOIOpen PDF
  22. 22.
    Elefteriades JA. Natural history of thoracic aortic aneurysms: indications for surgery, and surgical versus nonsurgical risks. Ann Thorac Surg. 2002;74(5):S1877-S1880.
    PubMed-indexed article2002

    In risk/benefit analysis the accumulated data strongly support a policy of preemptive surgical extirpation of the asymptomatic aneurysmal thoracic aorta to prevent rupture and dissection.

    PubMedDOI
  23. 23.
    Coselli JS, LeMaire SA, Preventza O, et al. Outcomes of 3309 thoracoabdominal aortic aneurysm repairs. J Thorac Cardiovasc Surg. 2016;151(5):1323-1337.
    PubMed-indexed articleRegistry / cohort2016

    The data suggest that thoracoabdominal aortic aneurysm repair, when performed at an experienced center, can produce respectable outcomes and predictors of early death and other adverse postoperative outcomes are described.

    PubMedDOIOpen PDF
  24. 24.
    Crawford ES, DeNatale RW. Thoracoabdominal aortic aneurysm: observations regarding the natural course of the disease. J Vasc Surg. 1986;3(4):578-582.
    PubMed-indexed article1986
    PubMedDOI
  25. 25.
    Estrera AL, Sandhu HK, Charlton-Ouw KM, et al. A Quarter Century of Organ Protection in Open Thoracoabdominal Repair. Ann Surg. 2015;264(5):896-903.
    PubMed-indexed articleRegistry / cohort2015

    Open DTAA and TAAA repair can be performed with acceptable early and late outcomes, and it is the high-risk subgroup that can now be targeted for endovascular techniques.

    PubMedDOI
  26. 26.
    Bischoff MS, Brenner RM, Scheumann J, et al. Staged approach for spinal cord protection in hybrid thoracoabdominal aortic aneurysm repair. Ann Cardiothorac Surg. 2012;1(3):325-328.
    PubMed-indexed article2012

    A new understanding of spinal cord perfusion has been termed the Collateral Network Concept (CNC), which provides insight into the anatomy of the extensive vascular network surrounding the spinal cord, and its dynamic response to SA sacrifice.

    PubMedDOI

Educational use only

AI assists this editorial workflow. Published updates are human-reviewed before publication.

Not intended to diagnose, monitor, predict, prognose, treat, or alleviate disease.

Verify clinically relevant information against primary sources and current guidelines.

AI DisclosurePrivacyTermsCautions